In-Hospital Outcomes with Transfemoral Versus Transapical Access for Transcatheter Aortic Valve Replacement in Patients with Peripheral Arterial Disease
Ayman Elbadawi(Ain Shams University), J. Dawn Abbott(Brown University), Syed Yaseen Naqvi(University of Rochester Medicine), Mohamed Faher Almahmoud(The University of Texas Medical Branch at Galveston), Abir Zainal(Harvard University), Ahmed Mahmoud(University of Florida), Michael Megaly(St. John Medical Center), Marwan Saad(Ain Shams University), Islam Y. Elgendy(Harvard University), Ahmed Altaweel(The University of Texas Medical Branch at Galveston), Neal S. Kleiman(Houston Methodist)
Cited by 10
Related Papers
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2
|Circulation|2002|652
Intravenous Platelet Blockade with Cangrelor during PCI
|New England Journal of Medicine|2009|643
Platelet Inhibition with Cangrelor in Patients Undergoing PCI
|New England Journal of Medicine|2009|618